Validation of the STarT Back Screening Tool in the Military

Sponsor
Brooke Army Medical Center (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT03127826
Collaborator
(none)
290
1
2
50.8
5.7

Study Details

Study Description

Brief Summary

This is a trial to validate the use of the STarT Back Screening Tool (SBST) in the Military Health System for patients with low back pain presenting to primary care.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Risk Stratified Care
  • Procedure: Usual Care
N/A

Detailed Description

Subjects with low back pain presenting to primary care will be enrolled in a study that aims to evaluate the utility of the SBST for providing risk-stratified care. The concept of this approach revolves around matching treatment to patients based on their risk for developing chronic disability from back pain. Those at low risk receive less treatment, and those at high risk need more specialized treatment, that includes psychosocially-focused and cognitive considerations. This approach will be compared to usual care, where general practitioners carry out the course of action they think best for each patient, without any other guidance. Patients will be followed for 1 year.

Study Design

Study Type:
Interventional
Actual Enrollment :
290 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Masking Description:
Primary care providers will be unaware of risk stratification scores.
Primary Purpose:
Treatment
Official Title:
Validation of the STarT Back Screening Tool in the Primary Care Management of Low Back Pain in the Military Health System: A Randomized Trial of Risk-stratified vs. Usual Care
Actual Study Start Date :
Apr 7, 2017
Actual Primary Completion Date :
Feb 26, 2021
Actual Study Completion Date :
Jul 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Usual Care

"Managing Low Back Pain" pamphlet from DoD/VA No specific guidance regarding physical therapy (PT) or other referrals, thus decision to refer or not will be made by the primary care manager (PCM) according to their preference

Procedure: Usual Care
Usual care at the general practitioner's discretion

Experimental: Risk Stratified Care

"Managing Low Back Pain" pamphlet from DoD/VA Self-management education and tools 2-item spinal manipulation screening/delivery if indicated Low Risk: Home Exercise Program as indicated No referral for ongoing physical therapy Medium Risk and High Risk Referral to physical therapy for ongoing care at physical therapists discretion Managed by a "psychologically informed physical therapy" trained physical therapist

Procedure: Risk Stratified Care
Physical therapists providing care will all have attended live training in PIPT principles and be involved in monthly continuing education on these principles. The use of specific principles is guided by the patient's risk stratification (as determined by the STarT Back Tool). Medium Risk: - Reassurance will be provided to address specific concerns related to their LBP and implications on work High Risk: - Physical therapy will be psychologically augmented with the assessment of biopsychosocial risk factors and the adoption of cognitive behavioral principles that explore patient concerns and address unhelpful beliefs and behaviors, including tailored education (e.g., stress management and pain neuroscience), graded exercise, & graded exposure

Outcome Measures

Primary Outcome Measures

  1. Roland-Morris Disability Questionnaire (RMDQ) [1 year]

    The focus of the interventions is directed towards the secondary prevention of disabling back pain. The RMDQ will be used to assess physical disability. The RMDQ is a recommended disability measure that it is widely used in LBP studies in primary care and was the primary outcome used in the STarT Back trial by Hill et al. (2011). The form provides 24 statements and prompts the participant by stating "When your back hurts, you may find it difficult to do some of the things you normally do." Then it states, "Mark only the sentences that describe you today." Examples include "I avoid heavy jobs around the house because of my back" and "I find it difficult to turn over in bed because of my back". Scores are calculated by percent improvement from baseline to post-intervention [(points of improvement made/total items checked at baseline) x 100]

Secondary Outcome Measures

  1. Patient Acceptable Symptom Scale (PASS) [1 year]

    Often defined as "the highest level of symptoms beyond which patients consider themselves well." This outcome measure has been used in previous studies looking at the effects of cervical thoracic thrust manipulation on shoulder pain. The question that will be asked to assess this level is, "Taking into account all the activities you have during your daily life, your level of pain, and also your functional impairment, do you consider that your current state is satisfactory?" Individuals who respond "yes" will be categorized as a success."

  2. Credibility Expectancy Questionnaire (CEQ) [1 year]

    The CEQ is a 6-item self-report measure evaluating treatment credibility and expectations for improvement. This will be assessed at baseline after treatment group assignment is revealed to provide descriptive information about participants' perceptions of their treatment assignment and optimism for improvement. The CEQ may be used as a covariate if perceptions differ meaningfully between groups as participants' initial perceptions of treatment credibility can impact outcomes.

  3. Patient Reported Outcomes Measurement Information System 57-Item Profile v 2.0 (PROMIS-57) [1 year]

    The PROMIS 57 efficiently assesses several outcomes important to patients including pain intensity and interference, sleep disturbance, anxiety, depression, fatigue, and social role participation using items developed with rigorous methodology and patient input. This is a 57-item questionnaire with 8 questions per domain.

  4. EuroQoL (EQ-5D) [1 year]

    The EQ-5D is a generic quality of life questionnaire that will assess quality of life on a scale that can be referenced to other disease conditions. The EQ-5D covers 5 domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each domain has 3 response categories: level 1, "no problems"; level 2, "some problems"; and level 3, "inability or extreme problems." Responses are combined to give a 5-digit descriptive health state classification (e.g., 11222). The EQ-5D yields a total of 243 possible health states. Valuations for each health state are available. The EQ-5D is commonly used in economic evaluation of interventions and cost-effectiveness analysis.

  5. Healthcare Utilization [2 years]

    Low back pain related healthcare costs

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Males and females who are between the ages of 18-50 years old

  2. Primary complaint of LBP for any duration, with or without associated radiculopathy

  3. Can speak and understand English

  4. Be willing and able to give full, informed written consent

Exclusion Criteria:
  1. Red Flags: Any potentially serious or systemic disorders (e.g., cauda equina compression, inflammatory arthritis, compression fracture, malignancy, infection, severe neurological progression), serious illness or comorbidity

  2. Spinal surgery in the past 24 months

  3. Current pregnancy (or within the last 6 months)

  4. Already receiving treatment (other than primary care) for this episode of LBP

  5. Inability to attend regular treatment sessions

  6. Pending litigation or a medical evaluation board

Contacts and Locations

Locations

Site City State Country Postal Code
1 Brooke Army Medical Center San Antonio Texas United States 78219

Sponsors and Collaborators

  • Brooke Army Medical Center

Investigators

  • Principal Investigator: Daniel Rhon, DPT, DSc, Director of Clinical Outcomes Research, Center for the Intrepid

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dan Rhon, Director of Clinical Outcomes Research at the Center for the Intrepid, Brooke Army Medical Center
ClinicalTrials.gov Identifier:
NCT03127826
Other Study ID Numbers:
  • C.2016.047d
First Posted:
Apr 25, 2017
Last Update Posted:
Jun 1, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dan Rhon, Director of Clinical Outcomes Research at the Center for the Intrepid, Brooke Army Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 1, 2022